Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.9796 | 89 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.31238 | 90 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.1336 | 89 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.27792 | 89 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.75646 | 92 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.8029 | 89 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.85354 | 89 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.22915 | 90 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.3976 | 91 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.24731 | 90 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.18217 | 90 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.13351 | 89 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.16526 | 90 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.24363 | 90 |